Related Experiment Video
Updated: Jun 12, 2026
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
Beneficial effects of magnolol in a rodent model of endotoxin shock
Yung-Chieh Tsai1, Pao-Yun Cheng, Ching-Wen Kung
1Center for Reproductive Medicine, Chi-Mei Foundation Hospital, Tainan, Taiwan.
Abstract:
Magnolol is a compound extracted from the Chinese medicinal herb Magnolia officinalis. It has multiple pharmacological effects, notably as an anti-oxidant. The aim of this study was to evaluate the effects of magnolol on sepsis induced by intravenous (i.v.) administration of lipopolysaccharide (LPS; 10 mg/kg) in anaesthetized Wistar rats. Magnolol (4 microg/kg, i.v.) was administered at 30 min after LPS injection. Post-treatment with magnolol significantly attenuated the deleterious haemodynamic changes (e.g., hypotension and bradycardia) caused by LPS. Meanwhile, magnolol significantly inhibited the elevation of plasma levels of tumor necrosis factor alpha, glutamate-oxaloacetate transaminase, glutamate-pyruvate transaminase and blood urine nitrogen caused by LPS. The induction of inducible nitrous oxide (NO) synthase and the overproduction of NO and superoxide anions by LPS were also significantly reduced by post-treatment with magnolol. Moreover, the plasma level of the thrombin-antithrombin complex following administration of LPS was also reduced by post-treatment with magnolol. Thus, the beneficial effects of magnolol on LPS-induced sepsis result from its anti-inflammatory, anti-coagulatory, and anti-oxidant effects.
Insights
Magnolol, an antioxidant from Magnolia officinalis, protected rats against sepsis. It improved hemodynamics and reduced inflammatory markers, showing potential therapeutic benefits.
Area of Science:
- Pharmacology
- Toxicology
- Natural Products
Background:
- Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
- Lipopolysaccharide (LPS) is a potent endotoxin that can induce a sepsis-like state.
- Magnolol, a bioactive compound from Magnolia officinalis, exhibits antioxidant and anti-inflammatory properties.
Purpose of the Study:
- To investigate the protective effects of magnolol against LPS-induced sepsis in a rat model.
- To evaluate magnolol's impact on hemodynamic parameters, organ damage markers, and inflammatory mediators during sepsis.
Main Methods:
- Sepsis was induced in anesthetized Wistar rats via intravenous LPS administration.
- Magnolol was administered intravenously 30 minutes post-LPS injection.
- Hemodynamic changes, plasma levels of liver enzymes, blood urea nitrogen, nitric oxide (NO), and thrombin-antithrombin complex were assessed.
Main Results:
- Magnolol post-treatment significantly attenuated LPS-induced hypotension and bradycardia.
- It inhibited the elevation of liver enzymes, blood urea nitrogen, and inflammatory markers like tumor necrosis factor alpha.
- Magnolol reduced inducible nitric oxide synthase (iNOS) expression, nitric oxide (NO) and superoxide anion overproduction, and thrombin-antithrombin complex levels.
Conclusions:
- Magnolol demonstrates significant protective effects against LPS-induced sepsis in rats.
- Its benefits are attributed to its combined anti-inflammatory, anticoagulant, and antioxidant activities.
- Magnolol shows potential as a therapeutic agent for sepsis management.
